Colonoscopy proves cost-effective in young patients

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 11
Volume 17
Issue 11

Conducting colonoscopies for people in their mid 50s can save money, according to research presented at the 2008 American College of Gastroenterology meeting in Orlando, Fla. The savings averages $2 for every dollar spent, the study found.

Conducting colonoscopies for people in their mid 50s can save money, according to research presented at the 2008 American College of Gastroenterology meeting in Orlando, Fla. The savings averages $2 for every dollar spent, the study found.

Jianjun Li, MD, and colleagues at New York’s Maimonides Medical Center reported results of a study involving free screening colonoscopies for 248 consecutive patients (average age of 55). Nearly 45% had polyps. Follow-up testing demonstrated that fi ve individuals had early-stage colon cancer, and 22 had polyps larger than 1 cm.

The screening program cost $390,000. If colon cancer treatment had been delayed until the Medicare eligibility age of 65, the cost would have been nearly $1.3 million, Dr. Li said. If these patients had not been screened, their disease would have progressed undetected, said Judy Yee, MD, vice chair of radiology at the University of California, San Francisco. As people grow older, their risk of developing polyps increases, she said.

Recent Videos
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
4 experts are featured in this series.
Based on a patient’s SCLC subtype, and Schlafen 11 status, patients will be randomly assigned to receive durvalumab alone or with a targeted therapy in the S2409 PRISM trial.
4 experts are featured in this series.
Daniel Peters, MD, aims to reduce the toxicity associated with AML treatments while also improving therapeutic outcomes.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Patients with AML will experience different toxicities based on the treatment they receive, whether it is intensive chemotherapy or targeted therapy.
A younger patient with AML who is more fit may be eligible for different treatments than an older patient with chronic medical conditions.
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Related Content